Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people. (2023)

First Author: Dambha-Miller H
Attributed to:  Epidemiological contribution to primary and secondary prevention of diabetes and obesity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.88769

Publication URI: https://www.repository.cam.ac.uk/handle/1810/341343

Type: Journal Article/Review